Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 09, 2019 for Raksha Sudhir Valia Sun Pharmaceutical Industries Ltd - 524715 - Closure of Trading Window
This is to inform you that in compliance with the Company''s Code of Conduct for prevention of Insider Trading, the window closure for trading by Designated Persons of the Company shall be with effect from Tuesday, 1st Octoher, 2019 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and half year ended 30th September,2019. The date of Board Meeting of the Company for declaration of the financial results for quarter and half year ended on 30th September, 20 19 will be intimated in due course. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate Antacid Ranitidine under cancer watch
Antacid Ranitidine under cancer watchIn India, a host of companies including GalxoSmithKline & Sun Pharma sell over 180 versions of the drug. Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation under regulation 39(3) SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation under regulation 39(3) Sun Pharmaceutical Industries promoter revokes more pledged shares
Post revocation, Sanghvi Finance's pledged shareholdings reduced to 4.3% from 5.21% SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanghvi Finance Pvt Ltd
Sun Pharma arm acquires remaining 3.04 % stake in PJSC Biosintez
Sun Pharma subsidiary Sun Pharma (Netherlands) BV already had 96.96% stake in pharma firm PJSC Biosintez prior to the purchase of these shares.Cash consideration of $ 815,201.99 was paid to shareholders who tendered their respective shares in the mandatory tender offer Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015